Pharmacological treatment strategies in the non-responsive schizophrenic patient

International Clinical Psychopharmacology

Volumn 11, Issue SUPPL. 2, 1996, Pages 67-71

  Barnes, T R E ^a   McEvedy, C J B ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Antidepressants; Benzodiazepines; Carbamazepine; Clozapine; Lithium; Neuroleptic; Schizophrenia; Treatment resistance

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; PROPRANOLOL; VALPROIC ACID;

CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029989771     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199605002-00011     Document Type: Conference Paper

References (50)

1. Barnes TRE (1994) Issues in the clinical assessment of negative symptoms [editorial review]. Curr Opin Psychiatry 7:35-38.
2. Barnes TRE, Pantelis C (1992) Treatment-resistant schizophrenia. Schizophr Monitor 2:1-4.
3. Bondolfi G, Baumann P, Patris M, et al. (1995) A randomised double-blind trial of risperidone versus clozapine for treatment-resistant chronic schizophrenia [abstract]. Eur Neuropsychopharmacol 5:349.
4. Borison RL, Diamond BI, Sinha D (1988) Clozapine withdrawal rebound psychosis. Psychopharmacol Bull 24:260-263.
5. Brenner HD, Dencker SJ, Goldstein MJ, et al. (1990) Defining treatment refractoriness in schizophrenia. Schizophr Bull 16:551-562.
6. Breier A, Buchanan RW, Irish D, Carpenter WT (1993) Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hosp Community Psychiatry 44:1145-1149.
7. Bryois C, Ferrero F (1993) Clinical observation of 11 patients under clozapine-lithium association. Eur Psychiatry 8: 213-218.
8. Buchanan RW (1995) Clozapine: efficacy and safety. Schizophr Bull 21:579-591.
9. Carpenter WT, Conley RR, Buchanan RW, et al. (1995) Patient response and resource management: Another view of clozapine treatment of schizophrenia. Am J Psychiatry 152: 827-832.
10. Christison GW, Kirch DG, Wyatt RJ (1991) When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophr Bull 17:217-245.
11. Claghorn J, Honigfeld G, Abuzzahab FS, et al. (1987) The risks and benefits of clozapine versus chlorpromazine. J Psychopharmacology 7:377-384.
12. Cohen WJ, Cohen NH (1974) Lithium carbonate, haloperidol and irreversible brain damage. JAMA 230:1283-1287.
13. Collins PJ, Larkin EP, Schubsachs APW (1991) Lithium carbonate in chronic schizophrenia: a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatr Scand 84:150-154.
14. Conley RR, Schulz SC, Baker RW, et al. (1988) Clozapine efficacy in schizophrenic non-responders. Psychopharmacol Bull 24:269-274.
15. Csernansky JG, Riney SJ, Lombroso L, et al. (1988) Double-blind comparison of alprazolam, diazepam and placebo for the treatment of negative schizophrenic symptoms. Arch Gen Psychiatry 45:655-659.
16. Delva NJ, Letemendia FJ (1986) Lithium treatment in schizophrenia and schizoaffective disorders. Edited by Kerr A, Snaith P. In Contemporary Issues in Schizophrenia. London: Royal College of Psychiatrists; pp 381-396.
17. Fitton A, Benfield P (1993) Clozapine: an appraisal of the pharmacoeconomic benefits in the treatment of schizophrenia. Pharmacoeconomics 4:131-156.
18. Growe GA, Crayton JW, Klass DB, et al. (1979) Lithium in chronic schizophrenia. Am J Psychiatry 136:454-455.
19. Herrera JM, Costa I, Sramek J, et al. (1988) Clozapine in refractory schizophrenia: preliminary findings. Schizophr Res 1:305-306.
20. Hirsch SR, Barnes TRE (1994) Clinical use of high-dose neuroleptics. Br J Psychiatry 164:94-96.
21. Holden JM, Itil TM, Keskiner A, et al. (1968) Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia. Compr Psychiatry 9:633-643.
22. Johns CA, Thompson JW (1995) Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy. Schizophr Bull 21:607-619.
23. Kahn EM, Schulz SC, Perel JM, Alexander JE (1990) Change in haloperidol level due to carbamazepine: a complicating factor in combined medication for schizophrenia. J Clin Psychophannacol 10:54-57.
24. Kane JM, Honigfeld G, Singer J, et al. (1988) Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796.
25. Kanter GL, Yerevsanian BI, Ciccone JR (1984) Case report of a possible interaction between neuroleptics and carbamazepine. Am J Psychiatry 141:1101-1102.
26. Kinon BJ, Kane JM, Johns C, et al. (1993) Treatment of neuroleptic-resistant schizophrenia relapse. Psychopharmacol Bull 29:309-314.
27. Lieberman J, Alvir JMJ, Woerner M, et al. (1992) Prospective study of psychobiology in first episode schizophrenia at Hillside Hospital. Schizophr Bull 18:351-371.
28. Lingjaerde O, Engstrand E, Ellingsen P, et al. (1979) Antipsychotic effect of diazepam when given in addition to neuroleptics in chronic psychotic patients: a double-blind clinical trial. Curr Ther Res 26:505-514.
29. MacMillan JF, Crow TJ, Johnson AL, Johnstone EC (1986) The Northwick Park study of first episodes of schizophrenia, III. Short term outcome in trial entrants and trial eligible patients. Br J Psychiatry 148:128-133.
30. Marder SR, Meibach RC (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 152:825-835.
31. Meltzer HY (1995a) Atypical antipsychotic drug therapy for treatment-resistant schizophrenia. In Schizophrenia. Edited by Hirsch SR, Weinberger DR. Oxford: Blackwell Science; pp 485-502.
32. Meltzer HY (1995b) Clozapine: is another view valid? [editorial]. Am J Psychiatry 152:821-825.
33. Miller F, Menninger J (1987) Lithium-neuroleptic neurotoxicity is dose-dependent. J Psychopharmacol 7:89-91.
34. Neppe VM (1988) Carbamazepine in non-responsive psychosis. J Clin Psychiatry 49:22-30.
35. Nestoros JN, Nair NPV, Pulman JR, et al. (1988) High doses of diazepam improve neuroleptic resistant chronic schizophrenic patients. Psychopathology 81:42-47.
36. Polvsen UJ, Noring U, Fog R, et al. (1985) Tolerability and therapeutic effect of clozapine. Acta Psychiatr Scand 71: 176-185.
37. Ruskin P, Averbukh I, Belmaker RH, et al. (1979) Benzodiazepines in chronic schizophrenia. Biol Psychiatry 14:557-558.
38. Safferman A, Lieberman JA, Kane JM, et al. (1991) Update on the clinical efficacy and side-effects of clozapine. Schizophr Bull 17:247-261.
39. Schulz SC, Kahn EM, Baker RW, Conley RR (1990) Lithium and carbamazepine augmentation in treatment-refractory schizophrenia. In The Neuroleptic Nonresponsive Patient: Characterisation and Treatment. Edited by Angrist B, Schulz SC. Washington, DC: American Psychiatric Press; pp 109-136.
40. Shalev A, Hermesh H, Rothberg J, et al. (1993) Poor neuroleptic response in acutely exacerbated schizophrenic patients. Acta Psychiatr Scand 87:86-91.
41. Simhandl C, Meszaros K (1992) The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review. J Psychiatry Neurosci 17:1-14.
42. Siris SG (1993) Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications. Br J Psychiatry 163 (suppl 22):66-78.
43. Siris SG, Adan F, Cohen M, et al. (1988) Post-psychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 145:1532-1537.
44. Small JG, Kellams JJ, Milstein V, Moore JA (1975) A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. Am J Psychiatry 132:1315-1317.
45. Thompson C (1994) The use of high-dose antipsychotic medication. Br J Psychiatry 164:448-458.
46. Wilson WH (1993) Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial. Psychopharmacology 111:359-366.
47. Wolkowitz OM, Breier A, Doran A, et al. (1988) Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: preliminary results. Arch Gen Psychiatry 45:664-671.
48. Wolkowitz OM, Turetsky N, Reus VI, et al. (1992) Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Psychopharmacol Bull 28:291-295.
49. Wolkowitz OM, Rapaport MH, Pickar D (1990) Benzodiazepine augmentation of neuroleptics. In The Neuroleptic-nonresponsive Patient: Characterization and Treatment. Edited by Angrist B, Schulz SC. Washington, DC: American Psychiatric Press; pp 89-108.
50. Yerevanian BI, Hodgman CH (1985) A haloperidol-carbamazepine interaction in a patients with rapid-cycling bipolar disorder [letter]. Am J Psychiatry 142:785-786.